Concepedia

I. Ou

IO

Statistics

Publications

2

Citations

25

H-Index

2

Active since

2015

I. Ou is an author specializing in pharmacology, oncology, and alk inhibition.

Publications per year

2015–2015

2

Publications

2

29LBA Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements

Salvatore Siena, Alexander Drilon, I. Ou et al. · European Journal of Cancer · 2015 · 14 citations

Medicine, Oncology, Pharmacology +17

3101 Updated efficacy and safety results from a global phase 2, open-label, single-arm study (NP28673) of alectinib in crizotinib-refractory ALK+ non-small-cell lung cancer (NSCLC)

Fabrice Barlési, Anne‐Marie C. Dingemans, I. Ou et al. · European Journal of Cancer · 2015 · 11 citations

Medicine, Oncology, Pharmacology +16

1–2 of 2